Visiongain’s latest report, Pharmaceutical Packaging Market Report 2026-2036, provides detailed forecasts and strategic analysis across materials, product types, packaging formats, and end-user segments, including technology trends, trade and supply chain dynamics, and competitive positioning.
The global pharmaceutical packaging market is projected to grow from US$188.4 billion in 2026 to US$436.5 billion by 2036, at a CAGR of 8.8% during the forecast period.
The market is expected to add significant value, driven by rising demand for biologics and injectable therapies, increasing regulatory requirements, and expansion of pharmaceutical manufacturing globally.
Key Market Insights
The global pharmaceutical packaging market will reach US$436.5 billion by 2036, growing at a CAGR of 8.8%
Growth is driven by biologics expansion, regulatory compliance requirements, and rising pharmaceutical production
Key regions: North America, Europe, Asia Pacific
Leading companies: Amcor plc, Gerresheimer AG, Schott AG, West Pharmaceutical Services Inc., Aptar Group Inc.
Key trend: increasing adoption of smart packaging and traceability systems
Download Free Sample Report (incl. forecasts, market data, and methodology):
Market Drivers
Rising Demand for Drug Delivery Devices and Blister Packaging
Demand for advanced drug delivery systems and blister packaging is increasing as pharmaceutical products become more complex and require precise dosing and enhanced protection. Unit-dose blister formats improve adherence, reduce contamination risks, and support safe handling across a wide range of therapies.
Growing Healthcare Expenditure and Pharma Industry in Emerging Countries
Healthcare investment is rising across emerging markets, increasing access to medicines and expanding pharmaceutical production. This is driving sustained demand for packaging formats such as vials, bottles, and prefilled syringes, alongside growing need for sterile and compliant solutions.
Technology & Innovation
Smart Packaging and Serialization
Serialization and smart packaging technologies are transforming pharmaceutical packaging into a data-enabled interface. Solutions such as RFID and NFC labels enable real-time tracking, improve supply chain visibility, and support compliance with global regulatory frameworks while strengthening anti-counterfeiting measures.
Trade & Supply Chain Dynamics
Global trade dynamics are increasingly shaping the pharmaceutical packaging market, with tariffs, geopolitical tensions, and regulatory frameworks impacting supply chains and production costs.
The market relies on globally sourced materials such as glass, polymers, and aluminium, creating exposure to tariffs and regulatory variation across regions. US trade tariffs are increasing procurement complexity and encouraging regionalisation of manufacturing.
Commercial Impact:
Cost pressure: Packaging manufacturers face rising input and compliance costs Supply chain shifts: Increased focus on local sourcing and regional production Margin implications: Cost increases are being passed through the value chain Competitive positioning: Larger, integrated players gain advantage through scale and resilience
Market Opportunities
Adoption of Smart Packaging Technologies
Smart packaging solutions are enabling real-time authentication, traceability, and patient engagement. This creates opportunities to reduce counterfeiting risks and improve supply chain transparency, particularly for high-value therapies.
Expansion of Biologics and Injectable Therapies
Growth in biologics and complex drug delivery systems is increasing demand for specialised packaging such as pre-filled syringes and high-quality glass vials, supporting long-term market expansion.
Competitive Landscape
The major players operating in the pharmaceutical packaging market include:
Amcor plc
Gerresheimer AG
Schott AG
West Pharmaceutical Services Inc.
Aptar Group Inc.
Catalent Inc.
CCL Industries Inc.
Nipro Corporation
Vetter Pharma International GmbH
McKesson Corporation
W. L. Gore & Associates Inc.
Stevanato Group
Owen-Illinois Inc.
SGD Pharma
These companies are focusing on innovation, partnerships, and expansion to strengthen their market positions.
Recent Developments
February 2026 – Amcor: Installed advanced additive manufacturing capabilities to accelerate packaging design and development
January 2026 – SCHOTT Pharma: Expanded specialty vial portfolio for sensitive biologic drugs
September 2025 – Gerresheimer: Expanded partnership to commercialise connected drug delivery platforms
Frequently Asked Questions
What is driving growth in the pharmaceutical packaging market? Growth is driven by increasing pharmaceutical production, demand for biologics, and stricter regulatory requirements.
How are trade and supply chain dynamics affecting the market? Tariffs and global sourcing dependencies are increasing costs and driving regionalisation of manufacturing.
Who are the leading companies in the market? Key players include Amcor plc, Gerresheimer AG, Schott AG, West Pharmaceutical Services Inc., and Aptar Group Inc.
Download Free Sample Report (incl. forecasts, market data, and methodology):
Established in 1998, Visiongain is an independent publisher of analyst-led market intelligence, delivering data-driven research, forecasts, and strategic insight across global industries and emerging markets. Visiongain supports evidence-based decision-making for investment, procurement, and long-term strategic planning.
